| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Revenue | $2.93B | -2.5% |
| R&D Expense | $57.1M | +1.4% |
| SG&A Expense | $249.3M | +2.1% |
| Operating Income | $247.9M | -42.8% |
| Pre-tax Income | -$31.0M | -124.0% |
| Income Tax | $56.9M | -28.1% |
| Net Income | -$176.1M | -1394.3% |
| EPS (Basic) | -$22.37 | -307.5% |
| EPS (Diluted) | -$22.37 |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $389.7M | -63.2% |
| Short-term Investments | $7.6M | -39.7% |
| Accounts Receivable | $388.0M | +11.5% |
| Inventory | $130.0M | -12.1% |
| Current Assets | $999.5M | -39.3% |
| Total Assets | $4.50B | -14.7% |
| Current Liabilities | $571.9M | -52.9% |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | $581.4M | -8.8% |
| Capital Expenditures | $567.9M | +5.0% |
| Investing Cash Flow | -$555.5M | +2.6% |
| Financing Cash Flow | -$662.0M | -211.7% |
| Free Cash Flow | $13.5M | -86.1% |
| -307.5% |
| Long-term Debt |
| $2.51B |
| -0.3% |
| Total Liabilities | $3.30B | -17.5% |
| Stockholders' Equity | $135.0M | -58.7% |